Theses
Date |
Theses
| |||
---|---|---|---|---|
29-11-2022
|
Fajri Gafar Optimization of tuberculosis treatment in children and adolescents. Epidemiological and pharmacological approaches. |
Prof. Katja Taixs | ||
31-10-2022
|
Johanne Rozema
Real-world studies of patients with myelodysplastic syndromes. Survival, treatment and outcomes in a population-based setting
|
Prof. Eric
van Roon
| ||
19-9-2022
|
Tanja Fens- Lazova Perspectives on medication safety and use. Pharmacoeconomics, public policy & practice and pharmacists education. |
Prof. Maarten Postma Prof. Eugène van Puijenbroek | ||
15-3-2022
|
Joep Scholl Signal detection in Pharmcovigilance. Time for a new era? |
Prof. Eugène van Puijenbroek Prof. Eelko Hak | ||
15-10-2021
|
Nanno Schreuder Exploring drug safety of radiopharmaceuticals. |
Prof. Eugène van Puijenbroek Prof. Jos Kosterink | ||
11-10-2021
|
Berdien Oortgiesen Real-worl studies of patients with mutiple myeloma. Future perspectives on symptom assessment and therapy. |
Prof. Eric van Roon | ||
27-11-2020
|
Karin Larmené Beld Ready to administer parental medication produced by hospital pharmacy |
Prof. K. Taxis Prof. M.J. Postma Prof. H.W. Frijlink | ||
12-10-2020
|
Sylvi Irawati Challenges in the use of preventive cardiovascular medications in Indonesia and The Netherlands |
Sylvi Irawati Prof. E. Hak Prof. K. Taxis | ||
06-10-2020
|
Sofa Dewi Alfian Adherence to antihypertensive or antihyperlipidemic co-medications in diabetis |
Prof. E. Hak Prof P. Denig | ||
08-05-2020
|
Yuanyuan Wang Effectiveness and safety of medicines used in COPD patients: pharmacoepidemiological studies |
Prof. E. Hak Prof. M. Boezen | ||
24-02-2020
|
Ivan Pradipta Improving treatment outcomes of tuberculosis: towards an antimicrobial stewardship program |
Prof. E. Hak Prof. J.W. Alffenaar | ||
10-02-2020
|
Ira Sianturi Exploring strategies to optimize pharmacotherapy with antiretrovirals in Papuans living with HIV |
Prof. K. Taxis Prof. B. Wilffert | ||
2019-03-22
|
Prof dr K Taxis Describing in older people. Development and evaluation of complex healthcare interventions | |||
2018-12-21
|
Prof dr K Taxis Information technology and medication safety | |||
2018-11-30
|
Prof dr EN van Roon Somatic monitoring of patients with mood and anxiety disorders: Problem definition, implementation and further explorations | |||
2018-09-14
|
Prof dr MJ Postma The public health impact of vaccination programmes in the Netherlands | |||
2018-06-29
|
Prof dr MJ Postma Distress and health-related quality of life in Indonesian type 2 diabetes mellitus outpatients | |||
2018-06-25
|
Prof dr MJ Postma Women's health from a global economic perspective | |||
2018-03-23
|
Prof dr EP van Puijenbroek Patient participation in pharmacovigilance | |||
2018-03-16
|
Prof dr K Taxis Medication use for acute coronary syndrome in Vietnam | |||
2018-01-26
|
Prof dr E Hak Improving influenza prevention. Why universal influenza vaccines are needed | |||
2017-08-12
|
Prof dr E Hak ADHD and atopic diseases. Pharmacoepidemiological studies | |||
2017-06-02
|
Prof dr EN van Roon Exploring optimal pharmacotherapy after bariatric surgery: where two worlds meet | |||
2017-04-24
|
Prof dr B Wilffert Paving ways for personalizing drug therapy during pregnancy | |||
2017-02-17
|
Prof dr MJ Postma HPV vaccination in Indonesia: A health-economic & comparative perspective | |||
2016-12-09
|
Prof dr MJ Postma Health economics of blood transfusion in Zimbabwe | |||
2016-12-09
|
Prof dr MJ Postma Risk modelling of transfusion transmissible infections | |||
2016-11-18
|
Prof dr MJ Postma Health economics of tick-borne diseases | |||
2016-09-23
|
Prof dr MJ Postma Health economics of screening for hypertension in Vietnam | |||
2016-09-12
|
Prof dr MJ Postma Health economics of targeted cancer therapies: A comparative analysis for Serbia and the Netherlands | |||
2016-06-21
|
Prof dr E Hak Real-world influenza vaccine effectiveness: New designs and methods to adjust for confounding and bias | |||
2016-06-17
|
Prof dr MJ Postma Economics of stratified medicine | |||
2016-06-17
|
Prof dr B Wilffert Optimizing treatment with psychotropic agents through precision drug therapy: It is not about the mean | |||
2016-03-11
|
Prof dr E Hak Age-period-cohort methodology: Confounding by birth cohort in cardiovascular pharmacoepidemiology | |||
2016-03-02
|
Prof dr IM van Langen
Data quality and methodology in studies on maternal medication use in relation to congenital anomalies
| |||
2016-02-26
|
Prof dr E Hak Statin treatment in type 2 diabetes patients | |||
2016-02-19
|
Bianca Mulder Prof dr E Hak Medication use during pregnancy and atopic | |||
2016-01-25
|
Priscilla Zetstra-van der Woude Prof dr LTW de Jong-van den Berg Data collection on risk factors in pregnancy | |||
2015-12-22
|
Prof dr MJ Postma Pharmacoeconomics of cardiovascular disease prevention | |||
2015-12-04
|
Prof dr E Hak Self-controlled designs to control confounding | |||
2015-11-17
|
Jan Wijnia Prof dr CI Mulder Early detection of mental and motor symptoms in the Wernicke-Korakoff Syndrome | |||
2015-09-25
|
Prof dr MJ Postma Enhancing adherence in patients with COPD: Targets, interventions & cost-effectiveness | |||
2015-09-16
|
Prof dr MJ Postma The influence and impact of the U.S. President's Emergency Plan for AIDS Relief (PERFAR) on blood transfusin services in Africa. Case studies from Namibia | |||
2015-06-26
|
Prof dr JJ de Gier Integrated Pharmaceutical Care. Cooperation between pharmacist, general practioner, and patient and the development of a pharmaceutical care plan | |||
2015-05-29
|
Prof dr MJ Postma Novel economic perspectives on prevention and treatment: case studies for paediatric, adolescent and adult infectious and chronic diseases | |||
2015-05-29
|
Prof dr MJ Postma Exploring new ways of measuring the economic value of vaccination with an application to the prevention of rotaviral disease | |||
2015-05-01
|
Prof dr MJ Postma Modelling chronic diseases for reimbursement purposes | |||
2014-11-03
|
Prof dr K Taxis Medication Safety in Vietnamese Hospitals. A focus on medication errors and safety culture | |||
2014-06-27
|
Prof dr MJ Postma Economic evaluations of non-traditional vaccinations in middle-income countries: Indonesia as a reference case | |||
2014-05-28
|
Prof dr E Hak Newly introduced vaccines. Effectiveness and deterninants of acceptance | |||
2014-04-07
|
Prof dr JJ de Gier Driving-impairing Medicines and Traffic Safety. Patients' Perspectives | |||
2013-10-28
|
Prof dr E Hak Influenza vaccination of health care workers | |||
2013-10-25
|
Prof dr AJM Loonen
Improving the physical health of people with severe mental illness : the need for tailor made care and uniform evaluation of interventions
| |||
2013-09-13
|
Prof dr MJ Postma Inequality Aversion to Posterity: Discounting Human Lives | |||
2013-06-28
|
Prof dr JRBJ Brouwers Clinical Pharmacology of Tuberculosis Drugs and Tuberculosis Control in Developing World. The involvement of Private Pharmacy and the individualization of treatment using Dried blood spot | |||
2013-06-07
|
Prof dr JJ de Gier Designing Health Care Services Using Systems Thinking: A Theory, A Method and their Application in the Dutch Community Pharmacy | |||
2013-05-31
|
Prof dr LTW de Jong-van den Berg Antibiotic drug use in children. Pharmacoepidemiologic, practical, social en enviromental perspectives in the Netherlands | |||
2013-04-17
|
Prof dr MJ Postma Health-economic Modelling of Human Papillomavirus Vaccination | |||
2013-03-22
|
Prof dr K Taxis Depressive Symptoms in Patients with Schizophrenia. Count symptoms that Count | |||
2013-02-25
|
Prof dr MJ Postma Cost and Effectiveness of Extended Vaccination Strategies against Pertussis and Pneumococcal Disease | |||
2013-02-25
|
Prof dr MJ Postma The Epidemiology and Cost-effectiveness of Vaccination Strategies against Infectious Diseases: a Focus on Varicella Zoster, Pandemic influenza A/H1N1 2009, Streptococcus Pneumonia | |||
2013-01-11
|
Prof dr B Wilffert Clinical Pharmacology of Antidepressants During Pregnancy | |||
2012-12-18
|
Prof dr MJ Postma Applying and Extending Mixed-effects Models in Health Economics and Outcomes Research | |||
2012-11-16
|
Prof dr LTW de Jong-van den Berg Drug Related Safety Issues Affecting Precnancy Outcome and Concerning Risk Minimisation Measures. Emphasis on Pregnancy Prevention Programmes | |||
2012-10-10
|
Prof dr E Hak
Prof dr JG Aaarnoudse Q Fever During Pregnancy. Lessons From the Dutch Epidemic | |||
2012-06-04
|
Prof dr AC van Grootheest Web-based intensive monitoring : a patient based pharmacovigilance tool | |||
2012-03-16
|
Prof dr MJ Postma The value of personalized approaches to improve pharmacotherapy in renal disease | |||
2012-02-24
|
Prof dr JJ de Gier Psychotropic medications and traffic safety. Contributions to risk assessment and risk communication | |||
2012-01-27
|
Prof dr MJ Postma Health economics of new and under-used vaccines in developing countries: state-of-the-art analyses for hepatitis B and rotavirus in Vietnam | |||
2011-12-09
|
Prof dr LTW de Jong vd berg Risk assessment of antiepileptic drugs in pregnancy | |||
2011-11-18
|
Prof dr AC van Grootheest The contribution of direct patient reporting to pharmacovigilance | |||
2011-02-04
|
Prof dr AJM Loonen Patterns of somatic disease in residential psychiatric patients : surveys of dyspepsia, diabetes and skin disease | |||
2011-02-04
|
Prof dr MJ Postma Cost-effectiveness of controlling infectious diseases from a public health perspective | |||
2010-10-08
|
Prof dr JRBJ Brouwers Pharmaceutical care by clinical pharmacists in patients with musculoskeletal disease | |||
2010-04-16
|
Prof dr MJ Postma The Economics of assisted reproduction. Costs and consequences of fertility treatments | |||
2010-01-11
|
Prof dr CHCM Buijs The use of a birth defects case-control monitoring system in studying the safety of medication use in pregnancy | |||
2010-01-08
|
Prof dr K Taxis Drug safety in patients with psychotic disorders | |||
2010-01-08
|
Prof dr MJ Postma Health-economics of interventions aimed at infectious diseases: dynamic modeling inevitable for reliable decision making | |||
2009-11-09
|
Prof dr JRBJ Brouwers Pharmacogenetics of Antipsychotic-Induced Parkinsonism and Tardive Dyskenesia: a Focus on African-Caribbeans and Slavonic Caucasians | |||
2009-06-26
|
Prof dr JRBJ Brouwers The optimization of coumarin anticoagulant therapy: Pharmacogenetics and computer assisted dose finding | |||
2009-06-12
|
Prof dr MJ Postma Health economics of cardiovascular & renal disease prevention : from clinical trials to real-life settings | |||
2009-05-11
|
Prof dr MJ Postma Cost-effectiveness of infectious disease interventions : combining economic modelling and web technology to support decision making | |||
2009-03-20
|
Prof dr LTW de Jong vd berg Drug use in pregnancy. Exploring the field of DMARDs in pregnancy | |||
2008-11-28
|
Prof dr JRBJ Brouwers Practice research in the field of gout. Clinical pharmacology of antihyperuricemic drugs | |||
2008-11-14
|
Prof dr LTW de Jong vd berg Improving care in paediatric asthma: patients, prescriptions, pharmacovigilance, pathogens, and particles | |||
2008-10-17
|
Prof dr DRA Uges Benzodiazepines and traffic safety. Forensic, analytical-toxicological and epidemiological aspects of driving under the influence of benzodiazepines | |||
2006-12-08
|
Prof dr LTW de Jong vd berg Drug safety in pregnancy. Studying and communicating teratogenic risks | |||
2006-10-02
|
Prof dr LTW de Jong vd berg Stimulant treatment in children: a Dutch perspective | |||
2006-09-15
|
Prof dr LTW de Jong vd berg Drug use in a population screening: Pharmacoepidemiological and pharmacoeconomical aspects | |||
2006-06-30
|
Prof dr JRBJ Brouwers Pharmacoeconomic Analysis of Proton Pump Inhibitor Therapy and interventions to Control Helicobacter pylori Infection | |||
2005-05-11
|
Prof dr JRBJ Brouwers Chemotherapy for patients with colorectal Cancer | |||
2005-03-11
|
Prof dr JRBJ Brouwers Practice research in the field of rheumatoid arthritis | |||
2004-12-17
|
Prof dr LTW de Jong vd berg Interventions on the principle of Pulmonary Medication Profiles | |||
2004-11-19
|
Prof dr JRBJ Brouwers The changing economic burden of HIV/AIDS in Italy | |||
2004-01-09
|
Prof dr LTW de Jong vd berg Pharmacoeconomics in infectious disease. The evaluation of prevention programmes | |||
2003-12-01
|
Prof dr JRBJ Brouwers Episodic tretment and prevention of paroxysmal atrial fibrilation: studies on flecainide and sotalol | |||
2003-11-18
|
Prof dr LTW de Jong vd berg Improving Pharmacovigilance and the Role of the Pharmacist | |||
2003-10-03
|
Prof dr LTW de Jong vd berg Drug Exposure from conception till adulthood | |||
2003-10-03
|
Prof dr LTW de Jong vd berg Pharmacy Data as a Tool for assessing Antypsychotic Drug Use | |||
2003-01-31
|
Prof dr LTW de Jong vd berg Assessing drug influences on urinary albumin excretion | |||
2002-06-07
|
Prof dr LTW de Jong vd berg pharmacotherapy in frail elderly | |||
2002-02-22
|
Prof dr JRBJ Brouwers Drug safety in hospitalised patients | |||
2001-11-10
|
Prof dr R Vos Connecting pre-marketing clinical research and medical practice : the case of the cardiovascular drugs
| |||
2001-06-18
|
Prof dr CHCM Buys Awareness and use of folic acid in the Netherlands: from science to practice | |||
2001-05-04
|
Prof dr LTW de Jong vd berg Managing Rational Pharmacotherapy in Hospitals: what about drug formularies and pharmacotherapeutic guidelines? | |||
2001-01-19
|
Prof dr R Vos Literature-based Discovery in Biomedicine | |||
2000-06-21
|
Prof dr CHCM Buys
The Use of Birth Defect Registries for Etiological Research.
| |||
2000-01-28
|
Prof dr ThFJ Tromp Pharmaceutical care, the future of pharmacy | |||
1998-10-16
|
Prof dr LTW de Jong vd berg Collaboration in healthcare, the tango to drug safety | |||
1998-01-30
|
Prof dr R Vos Adverse Drug Reactions in a Different Context; a scientometric approach towards adverse drug reactions as a trigger for the development of new drugs | |||
1995-09-22
|
Prof dr ThFJ Tromp Making News about Medicines | |||
1995-07-07
|
Prof dr H Wesseling A Field-oriented Postmarketing Surveillance Study on the Teratogen Acitretin | |||
1992-04-29
|
Prof dr MNG Dukes Drug Utilization Studies in Pregnancy; what can they contribute to safety assessment? | |||
1989-12-11
|
Prof dr DKF Meijer Drugs Looking for Diseases; a descriptive model for the process of innovative drug research with special reference to the development of beta blockers and the calcium antagonists |
Laatst gewijzigd: | 13 januari 2023 15:40 |